International Forum of Allergy and Rhinology Immunology and Allergy

Reply to Letter to the Editor Regarding “Dosing Interval Extension of Dupilumab in CRSwNP: Five Year Real World Outcomes” by Meulmeester et al.

Nicholas J. Campion, Dioni‐Pinelopi Petsiou, Florian C. Fally, Karina Berbalk, Noah F. Melamed, Aldine Tu, Christina Morgenstern, Fana Alem Kidane, Mohammed Zghaebi, Linda Liu, Minghao Pan, Tina J. Bartosik, Victoria Stanek, Katarina Gangl, Julia Eckl‐Dorna, Sven Schneider
Wiley · 2026-11-04 · DOI 10.1002/alr.70293
⬢ Cited by: 0 Crossref

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →